The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: A meta analysis

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 111, Issue 6, 2004, Pages 585-593

  Wyatt, Katrina M ^a,d   Dimmock, Paul W ^b   Ismail, Khaled M K ^b   Jones, Peter W ^c   O'Brien, P M Shaughn ^b  

^a Exeter and North Devon RDSU   (United Kingdom)

^b KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c KEELE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST;

ARTICLE; CLINICAL TRIAL; DATA BASE; DRUG EFFICACY; HEADACHE; HOT FLUSH; HUMAN; INSOMNIA; MATHEMATICAL COMPUTING; META ANALYSIS; NAUSEA; NIGHT SWEAT; PAIN; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; SIDE EFFECT; STANDARDIZATION; STATISTICAL ANALYSIS; SYMPTOMATOLOGY;

FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; PREMENSTRUAL SYNDROME; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS;

EID: 2942512800     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2004.00135.x     Document Type: Article

References (31)

1. O'Brien PMS. Premenstrual Syndrome. London: Scientific Blackwell Publishing, 1987.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC: American Psychiatric Association, 1994:714-718.
3. A survey to establish the awareness and opinions regarding severe PMS (PMDD) in five European countries. IPSOS RSL July 1999.
4. Schmidt P, Nieman L, Danaceau M, Adams L, Rubinow D. Differential behavioural effects of gonadal steroids in women with premenstrual syndrome and in control subjects. N Engl J Med 1998;338(4):209-216 (January 22).
5. Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone B, Mahesh VB. Progesterone metabolite allopregnenalone in women with premenstrual syndrome. Obstet Gynecol 1997;90:709-714.
6. Dimmock PW, Wyatt KM, Jones PW, O'Brien PMS. Efficacy of selective serotonin re-uptake inhibitors in premenstrual syndrome: a systematic review. Lancet 2000;356:1131-1136.
7. Sundstrom-Poroma I, Bixo M, Bjorn I, Nordg O. Compliance to antidepressant drug therapy for treatment of premenstrual syndrome. J Psychosom Obstet Gynaecol 2000;21(4):205-211.
8. Dodin S, Lemay A, Maheux R, Dumont M, Turcot-Lemay L. Bone mass in endometriosis patients treated with GnRH implant or danazol. Obstet Gynecol 1991;7:410-415.
9. Studd J, Leather AT. The need for addback with gonadotrophin-releasing hormone agonist therapy. Br J Obstet Gynaecol 1996;103(Suppl 14):1-4.
10. Henshaw C, Foreman D, Belcher J, Cox J, O'Brien S. Can one induce premenstrual symptomatology in women with prior hysterectomy and bilateral oophorectomy? J Psychosom Obstet Gynaecol 1996;17(1):21-28.
11. Plouffe L, Stewart K, Craft KS, Maddox MS, Rausch MD. Diagnostic and treatment results from a south-eastern academic center-based premenstrual syndrome clinic: the first year. Am J Obstet Gynecol 1993;169(2):295-307.
12. Johnson SR. Premenstrual syndrome therapy. Clin Obstet Gynecol 1998;41(2):405-421.
13. Jadad A, Moore M, Carrol D, et al. Assessing the quality of reports of randomised clinical trials; is blinding necessary? Control Clin Trials 1996;17:1-12.
14. Cohen J. Statistical Power Analysis for the Behavioural Sciences. New Jersey: Lawrence Erlbaum Associates, 1988.
15. Chatfield C. Statistics for Technology. London: Chapman & Hall, 1978.
16. Hasselblad V, Hedges LV. Meta-analysis of screening and diagnostic tests. Psychol Bull 1995;117:167-178.
17. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
18. Muse KN, Cetel NS, Futterman LA, Yen SSC. The premenstrual syndrome: effects of 'medical ovariectomy'. N Engl J Med 1984;311:1345-1349.
19. Freeman EW, Sondheimer SJ, Rickels K. Gonadotrophin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study. Psychopharmacol Bull 1997;33(2):303-309.
20. Brown CS, Ling FW, Anderson RN, Falmer RG, Arheart KL. Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial. Obstet Gynecol 1994;84:779-786.
21. Sundstrom I, Nyberg S, Bixo M, Hammarback S, Backstrom T. Treatment of premenstrual syndrome with gonadotrophin releasing hormone agonist in a low dose regimen. Acta Obstet Scand 1999;78:891-899.
22. Leather AT, Studd JWW, Watson NR, Holland EFN. The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study. Gynecol Endocrinol 1999;13(1):48-55 (February).
23. West CP, Hillier H. Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of premenstrual syndrome. Hum Reprod 1994;9(6):1058-1063.
24. Hammarback S, Backstrom T. Induced anovulation as treatment of premenstrual tension syndrome. Acta Obstet Gyencol Scand 1998;67:159-166.
25. DiCarlo C, Palomba S, Tommaselli GA, Guid M, Di Spiezio Sardo A, Nappi C. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil Steril 2001;75(2):380-384.
26. Mortola JF, Girton L, Fischer U. Successful treatment of severe premenstrual syndrome by combined use of gonadotrophjn-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab 1991;71:252A-252F.
27. Mezrow G, Shoupe D, Spicer D. Depot leuprolide acetate with estrogen and progestin addback for long term treatment of premenstrual syndrome. Fertil Steril 1994;62:932-937.
28. Wyatt KM, Dimmock PW, Jones P, O'Brien PMS. Vitamin B6 therapy - a systematic review of its efficacy in premenstrual syndrome. BMJ 1999;318:1375-1381.
29. Wyatt KM, Dimmock PW, Jones PJ, O'Brien PMS. Progesterone and progestagens: a systematic review of their efficacy in the management of premenstrual syndrome. BMJ 2001;323:776-780.
30. Surrey ES. Steroidal and nonsteroidal 'addback' therapy: extending safety and efficacy of gonadotrophin-releasing hormone agonist in the gynecologic patient. Fertil Steril 1995;64:673-685.
31. Hammarback S, Backstrom T, Holst J, von Schoultz B, Lyrenas S. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstet Gynecol Scand 1985;64(5):393-397.